Do you want to receive our research articles?
|
|
|
Dear Colleagues,
Welcome to our August issue of "Science Speaks"!
This month's topics will include an extract of our recently published article about clinical trials in Brazil as well as an article about trials in South Africa, both of which have become outsourcing hotspots. Furthermore, Karen Politis-Virk, our Director of Pharmaceutical and Biotech Research, will share her expert knowledge about global clinical trials with us.
Visit us at www.languageconnections.com and find out more about our services.
As your team of expert language service providers, we look forward to doing business with you. Please feel free to contact us with any questions or requests.
Enjoy!
|
| Issues Affecting Clinical Trials in Brazil |  Among Latin American emerging markets, Brazil is quickly becoming a dominant outsourcing location for clinical trials. This is mostly due to an improved regulatory environment, a large, ethnically/racially diverse patient population, as well as reduced costs and highly successful patient recruitment relative to more developed Western countries.
We have recently published an article in Informa Healthcare Clinical Research and Regulatory Affairs entitled "Addressing Issues Affecting Clinical Trials in Brazil" (June 2010, Vol. 27, No. 2, Pages 52-59) which provides a summary of the country's current clinical research environment.
Read more...
|
South Africa Today
|  Two
things distinguish South Africa from other countries in Africa: South
Africa is the most economically developed African country and it has
established better regulatory standards for conducting clinical trials.
In addition, several factors are responsible for the growth of clinical
research including a large, diverse patient population that for the most
part has not undergone previous treatment, and lower costs for clinical
research. However, in order to ensure that international ethical
standards are maintained, sponsors must be aware of the country's
patient demographics, acknowledging their respective languages and cultural practices. Poverty and illiteracy
must also be addressed in the context of informed consent procedures.
These issues should be addressed by companies outsourcing clinical
trials in the region.
Read more...
|
Expert Knowledge: Language and cultural barriers in global clinical trials
|  As
clinical globalization continues to increase, what best practices should
companies consider when looking to overcome language and cultural barriers?
Quality
translation is a key element in the success of global clinical trials, and
involves more than just simple translation from a source language into a targetlanguage. The translated text must be culturally adapted in order to avoid
being misconstrued. Linguistic and cultural issues can be overcome to a large
extent with proper clinical trial management. Translations must therefore be
performed by experts who are native speakers, are familiar with the culture,
and have a professional background in clinical research. Language service
providers and CROs with experience in a specific country or region are best
equipped to help to address such linguistic or cultural barriers.
Read more...
|
|
|
Sincerely,
Leo Galperin, President
Language Connections
Boston, MA
Tel. 617-731-3510
www.languageconnections.com
Wherever you do business, we speak the language.
|
|
|
